4 days Ago By Defense World Staff
Wells Fargo & Company MN lifted its position in VanEck Biotech ETF ( NASDAQ:BBH – Free Report ) by 5.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 75,826 shares of the company’s stock after buying an additional 4,064 shares during the quarter.
Wells Fargo & Company MN owned about 3.15% of VanEck Biotech ETF worth $11,902,000 as of its most recent SEC filing. A number of other institutional investors have also added to or reduced their stakes in BBH.
Jane Street Group LLC grew its position in shares of VanEck Biotech ETF by 401.7% in the 3rd quarter. Jane Street Group LLC now owns 8,348 shares of the company’s stock valued at $1,481,000 after acquiring an additional 6,684 shares during the period.
Farther Finance Advisors LLC bought a new position in VanEck Biotech ETF during the fourth quarter worth about $32,000. Independent Advisor Alliance acquired a new position in VanEck Biotech ETF during the fourth quarter worth approximately $250,000. HighTower Advisors LLC boosted its stake in shares of VanEck Biotech ETF by 12.
0% during the 4th quarter. HighTower Advisors LLC now owns 9,903 shares of the company’s stock worth $1,554,000 after acquiring an additional 1,058 shares during the period. Finally, SBI Securities Co.
Ltd. acquired a new position in shares of VanEck Biotech ETF during the 4th quarter worth approximately $81,000. 32.
05% of the stock is currently owned by institutional investors and hedge funds. VanEck Biotech ETF Price Performance NASDAQ:BBH opened at $147.74 on Wednesday.
The company has a market cap of $342.76 million, a P/E ratio of 29.88 and a beta of 0.
85. The firm’s fifty day moving average price is $158.38 and its two-hundred day moving average price is $163.
58. VanEck Biotech ETF has a one year low of $135.34 and a one year high of $183.
64. VanEck Biotech ETF Company Profile The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.
Featured Articles Five stocks we like better than VanEck Biotech ETF What is the Euro STOXX 50 Index? Beware of BigBear.ai: Insiders Are Selling—Should You? How to Short a Stock in 5 Easy Steps CrowdStrike Stock is a Buy as Cyberthreat Environment Expands How to Profit From Growth Investing Congress! Who Traded What During the Tariff-Induced Meltdown Want to see what other hedge funds are holding BBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Biotech ETF ( NASDAQ:BBH – Free Report ).
Receive News & Ratings for VanEck Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter ..
